Literature DB >> 9224464

Long-term follow-up of initially successful trabeculectomy.

T C Chen1, J T Wilensky, M A Viana.   

Abstract

OBJECTIVE: The purpose was to study the long-term outcomes of primary trabeculectomies that were successful at 1 year.
DESIGN: A retrospective study of patients with various types of glaucoma who had trabeculectomies that were successful at 1 year and who had a follow-up of at least 10 years. PARTICIPANTS: There were 40 patients (40 eyes) who had primary trabeculectomies that were successful at 1 year and who had a follow-up range of 10 to 21 years. INTERVENTION: Control of intraocular pressure (IOP) and disease progression was evaluated at 5, 10, and 15 years and at the last obtainable follow-up. MAIN OUTCOME MEASURES: Successful control of IOP was defined as IOP less than 21 mmHg or a reduction of 33% if preoperative IOP was less than 21 mmHg. Successful control of disease progression was defined as stable cup-disc ratios determined by examination, or color photographs or both, as well as stable visual fields.
RESULTS: If an eye was considered successful by IOP at 1 year, the probability of successful control of IOP was 82% at 5 years and 67% at 10 and 15 years. If an eye was considered successful by IOP at 1 year, the probability of successful control of disease progression at 5 years was 77%, at 10 years 61%, and at 15 years 48%. If an eye did not require further glaucoma surgery at 1 year, the probability that it still would not need further surgery at 5 years was 90%, at 10 years 75%, and at 15 years 67%. Forty percent of eyes had cataract extraction by the time of last follow-up examination.
CONCLUSIONS: Loss of IOP control and progression of glaucomatous damage occurs over time despite initial success at 1 year.

Entities:  

Mesh:

Year:  1997        PMID: 9224464     DOI: 10.1016/s0161-6420(97)30174-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  16 in total

1.  Course of exfoliation and simplex glaucoma after primary trabeculectomy.

Authors:  V Popovic; J Sjöstrand
Journal:  Br J Ophthalmol       Date:  1999-03       Impact factor: 4.638

2.  Conjunctival epithelium expression of HLA-DR in glaucoma patients and its influence on the outcome of filtration surgery.

Authors:  A Ihan; B Cvenkel
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

3.  Non-penetrating intracanalicular partial trabeculectomy via the ostia of Schlemm's canal.

Authors:  Alexey V Dashevsky; Ines M Lanzl; Konstantin E Kotliar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-09-23       Impact factor: 3.117

4.  Trabeculectomy combined with deep sclerectomy and scleral flap suture tension adjustment under an anterior chamber maintainer: a new modification of trabeculectomy.

Authors:  Ozcan R Kayikcioglu; Sinan Emre; Ziya Kaya
Journal:  Int Ophthalmol       Date:  2009-12-04       Impact factor: 2.031

5.  Evaluation of the Ex-PRESS(®) P-50 implant under scleral flap in combined cataract and glaucoma surgery.

Authors:  Valentín Huerva; Jordi Soldevila; Francisco J Ascaso; Laura Lavilla; M Jesús Muniesa; M Carmen Sánchez
Journal:  Int J Ophthalmol       Date:  2016-04-18       Impact factor: 1.779

6.  Matrix metalloproteinase gelatinase B (MMP-9) is associated with leaking glaucoma filtering blebs.

Authors:  Shravan K Chintala; Nan Wang; Shiri Diskin; Cynthia Mattox; Larry Kagemann; M Elizabeth Fini; Joel S Schuman
Journal:  Exp Eye Res       Date:  2005-10       Impact factor: 3.467

7.  Selective laser trabeculoplasty in treating post-trabeculectomy advanced primary open-angle glaucoma.

Authors:  Hongyang Zhang; Yangfan Yang; Jiangang Xu; Minbin Yu
Journal:  Exp Ther Med       Date:  2015-12-29       Impact factor: 2.447

8.  Risk factors for failures of trabeculectomies performed without antimetabolites.

Authors:  H Mietz; B Raschka; G K Krieglstein
Journal:  Br J Ophthalmol       Date:  1999-07       Impact factor: 4.638

9.  The rising cost of glaucoma drugs in Ireland 1996-2003.

Authors:  F A Knox; M Barry; B McGowan; C O'Brien
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

10.  Subconjunctival bevacizumab as an adjuvant in first-time filtration surgery for patients with primary glaucomas.

Authors:  Luis Gustavo Biteli; Tiago Santos Prata
Journal:  Int Ophthalmol       Date:  2013-02-07       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.